Page last updated: 2024-10-21

4-aminopyridine and Anterior Ischemic Optic Neuropathy

4-aminopyridine has been researched along with Anterior Ischemic Optic Neuropathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moster, ML1
Sergott, RC1
Leiby, BE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis[NCT01987167]Early Phase 125 participants (Actual)Interventional2013-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 4-aminopyridine and Anterior Ischemic Optic Neuropathy

ArticleYear
Dalfampridine Treatment in Nonarteritic Anterior Ischemic Optic Neuropathy.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2017, Volume: 37, Issue:3

    Topics: 4-Aminopyridine; Humans; Optic Neuropathy, Ischemic; Risk Factors

2017